NCT04439240
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Refractory Lymphoma
Explore clinical trials studying Refractory Lymphoma. Study availability and eligibility vary by location and protocol.
55 public trials
9 recruiting studies
Refractory Lymphoma trial results
NCT01742988
- Conditions
- Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- University of Chicago Medicine Chicago, Illinois, United States
NCT04439214
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +23 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00054808
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Genta Berkeley Heights, New Jersey, United States